BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 15864149)

  • 1. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
    Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
    Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
    Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
    Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
    Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
    Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
    Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
    Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
    Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
    J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
    Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
    Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
    Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
    J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a collagen-hydroxyapatite matrix in spinal fusion. A rabbit model.
    Tay BK; Le AX; Heilman M; Lotz J; Bradford DS
    Spine (Phila Pa 1976); 1998 Nov; 23(21):2276-81. PubMed ID: 9820906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
    Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
    Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
    Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
    Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion.
    Boden SD; Martin GJ; Morone M; Ugbo JL; Titus L; Hutton WC
    Spine (Phila Pa 1976); 1999 Feb; 24(4):320-7. PubMed ID: 10065514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion.
    Minamide A; Yoshida M; Kawakami M; Yamasaki S; Kojima H; Hashizume H; Boden SD
    Spine (Phila Pa 1976); 2005 May; 30(10):1134-8. PubMed ID: 15897826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.
    Kai T; Shao-qing G; Geng-ting D
    Spine (Phila Pa 1976); 2003 Aug; 28(15):1653-8. PubMed ID: 12897487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterolateral lumbar spine fusion with INFUSE bone graft.
    Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
    Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
    Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.
    Dawson E; Bae HW; Burkus JK; Stambough JL; Glassman SD
    J Bone Joint Surg Am; 2009 Jul; 91(7):1604-13. PubMed ID: 19571082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healos/recombinant human growth and differentiation factor-5 induces posterolateral lumbar fusion in a New Zealand white rabbit model.
    Magit DP; Maak T; Trioano N; Raphael B; Hamouria Q; Polzhofer G; Drespe I; Albert TJ; Grauer JN
    Spine (Phila Pa 1976); 2006 Sep; 31(19):2180-8. PubMed ID: 16946651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental spinal fusion with recombinant human bone morphogenetic protein-2.
    Schimandle JH; Boden SD; Hutton WC
    Spine (Phila Pa 1976); 1995 Jun; 20(12):1326-37. PubMed ID: 7676329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.
    Rao RD; Gourab K; Bagaria VB; Shidham VB; Metkar U; Cooley BC
    J Bone Joint Surg Am; 2009 May; 91(5):1199-206. PubMed ID: 19411469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
    Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.